Selenium metabolism and bioavailability

Biological Trace Element Research

Volumn 54, Issue 3, 1996, Pages 185-199

  Daniels, Lynne A ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

bioavailability; metabolism; review; Selenium; seleno cysteine; selenoproteins; transport

Indexed keywords

GLUTATHIONE PEROXIDASE; METHIONINE; SELENIUM; SELENOAMINO ACID; SULFUR; THYROXINE DEIODINASE;

BIOAVAILABILITY; HUMAN; INTESTINE ABSORPTION; METABOLISM; NUTRIENT; REVIEW;

ANIMALIA;

EID: 0029961460     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02784430     Document Type: Review

References (99)

1. J. F. van Vleet and V. J. Ferrans, Etiologic factors and pathologie alterations in selenium-vitamin E deficiency and excess in animals and humans, Biol. Trace Elem. Res. 33, 1-21 (1992).
2. K. Schwarz, and C. M. Foltz, Selenium as an integral part of factor 3 against dietary necrotic liver degeneration, J. Am. Chem. Soc. 70, 3292,3293 (1957).
3. A. Chen, F. Yang, J. Chen, X. Chen, Z. Wen, and K. Ge, Studies on the relation of selenium and Keshan disease, Biol. Trace Elem. Res. 2, 91-107 (1980).
4. H. B. von Stockhausen. Selenium in total parenteral nutrition, Biol. Trace Elem. Res. 15, 147-155 (1988).
5. O. A. Levander, The importance of selenium in total parenteral nutrition, Bull. N. Y. Acad. Med. 60, 144-155 (1984).
6. L. A. Daniels, R. A. Gibson, and K. Simmer, A randomized clinical trial of parenteral selenium supplementation in preterm infants (Abstract), Proc. Nutr. Soc. 53:(3)205A (1994).
7. L. A. Daniels, R. A. Gibson, K. Simmer, Selenium status in term and preterm infants (Abstract), Proc. Nutr. Soc. 53:(3)263A (1994).
8. G. Lockitch, Selenium: clinical significance and analytical concepts, Crit. Rev. Clin. Lab. Sci. 27, 483-541 (1989).
9. O. A. Levander, Considerations in the design of selenium bioavailability studies, Fed. Proc. 42, 1721-1725 (1983).
10. A. Böck, K. Forchhammer, J. Heider, W. Leinfelder, G. Sawers, B. Veprek, and F. Zinoni, Selenocysteine: the 21st amino acid, Mol. Microbiol. 5, 515-520 (1991).
11. G. F. Combs, Jr., S. B. Combs, The nutritional biochemistry of selenium, Annu. Rev. Nutr. 4, 257-280 (1984).
12. D. Behne, C. Weiss-Nowak, M. Kalcklösch, C. Westphal, H. Gessner, and A. Kyriakopoulos, Studies on the distribution and characteristics of new mammalian selenium-containing proteins, Analyst 120, 823-825 (1995).
13. R. F. Burk and K. E. Hill, Regulation of selenoproteins, Annu. Rev. Nutr. 13, 65-81 (1993).
14. J. R. Arthur, F. Nicol, and G. J. Beckett, The role of selenium in thyroid hormone metabolism and effects of selenium deficiency on thyroid hormone and iodine metabolism, Biol. Trace Elem. Res. 34, 321-325 (1992).
15. R. A. Sunde, Molecular biology of selenoproteins, Annu. Rev. Nutr. 10, 451-474 (1990).
16. A. Böck, K. Forchhammer, J. Heider, and C. Baron, Selenoprotein synthesis: an expansion of the genetic code, Trends Biochem. Sci. 16, 463-467 (1991).
17. J. R. Arthur, Selenium metabolism and function, Proc. Nutr. Soc. Aust. 17, 91-98 (1992).
18. H. J. Cohen, and N. Avissar, Molecular and biochemical aspects of selenium metabolism and deficiency, in Essential and Toxic Trace Elements in Human Health and Disease: An Update, A. S. Prasad, ed., Wiley-Liss Inc., New York, pp. 191-202 (1993).
19. R. F. Burk, Molecular biology of selenium with implications for its metabolism, FASEB J. 5, 2274-2279 (1991).
20. M. Yoshida, K. Iwami, and K. Yasumoto, Purification and immunochemical analysis of rat liver glutathione peroxidase, Agric. Biol. Chem. 46, 41-46 (1982).
21. 1, Biochem. J. 306, 851-856 (1995).
22. K. E. Hill, R R. Lyons, and R. F. Burk, Differential regulation of rat liver selenoprotein mRNAs in selenium deficiency, Biochem. Biophys. Res. Commun. 185, 260-263 (1992).
23. L. Jornot and A. F. Junod, Differential regulation of glutathione peroxidase by selenomethionine and hyperoxia in endothelial cells, Biochem. J. 306, 581-587 (1995).
24. J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, Selenium: biochemical role as a component of glutathione peroxidase, Science 179, 588-590 (1973).
25. G. C. Mills, Hemoglobin catabolism: I. glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown, J. Biol. Chem. 229, 189-197 (1957).
26. H. J. Cohen, M. Brown, J, Lyons, et al., Clinical physiological and biochemical consequences of human selenium deficiency, in Essential and Toxic Trace Elements in Human Health and Disease, A. S. Prasad, ed., Liss Inc., New York, pp. 201-210 (1988).
27. F. Ursini, M. Maiorino, M. Valente, L. Ferri, and C. Gregolin, Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides, Biochim. Biophys. Acta 710, 197-211 (1982).
28. K. R. Maddipati, C. Gasparski, and L. J. Marnett, Characterization of the hydroperoxide-reducing activity of human plasma, Arch. Biochem. Biophys. 254, 9-17 (1987).
29. K. R. Maddipati and L. J. Marnett, Characterization of the major hydroperoxide-reducing activity of human plasma: purification and properties of a selenium-dependent glutathione peroxidase, J. Biol. Chem. 262, 17,398-17,403 (1987).
30. R. F. Burk, Protection against free radical injury by selenoenzymes, Pharmacol. Ther. 45, 383-385 (1990).
31. N. Avissar, C. Eisenmann, J. G. Breen, S. Horowitz, R. K. Miller, and H. J. Cohen, Human placenta makes extracellular glutathione peroxidase and secretes it into maternal circulation, Am. J. Physiol. 267, E68-E76 (1994).
32. N. Avissar, J. R. Slemmon, I. S. Palmer, and H. J. Cohen, Partial sequence of human plasma glutathione peroxidase and immunologie identification of milk glutathione peroxidase as the plasma enzyme, J. Nutr. 121, 1243-1249 (1991).
33. C. Michiels, M. Raes, O. Toussaint, and J. Remacle, Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress, Free Radic. Biol. Med. 17, 235-248 (1994).
34. A. T. Diplock, F. A. Chaudry, The relationship of selenium biochemistry to selenium responsive disease in man, in Essential and Toxic Trace Elements in Human Health and Disease, A. S. Prasad, ed., Liss Inc., New York, pp. 211-226 (1988).
35. M. Maiorino, C. Gregolin, and F. Ursini, Phospholipid hydroperoxide glutathione peroxidase, Methods Enzymol. 186, 448-457 (1990).
36. H. M. Rea, C. D. Thomson, D. R. Campbell, and M. F. Robinson, Relation between erythrocyte selenium concentrations and glutathione peroxidase (EC 1.11.1.9) activities of New Zealand residents and visitors to New Zealand, Br. J. Nutr. 42, 201-208 (1979).
37. K. Takahashi, P. E. Newburger, and H. J. Cohen, Glutathione peroxidase protein: absence in selenium deficiency states and correlation with enzymatic activity, J. Clin. Invest. 77, 1402-1404 (1986).
38. K. Takahashi and H. J. Cohen, Selenium-dependent glutathione peroxidase protein and activity: immunological investigations on cellular and plasma enzymes, Blood 68, 640-645 (1986).
39. N. Avissar, J. C. Whitin, P. Z. Allen, I. S. Palmer, and H. J. Cohen, Antihuman plasma gluta-thione peroxidase antibodies: immunologie investigations to determine plasma glutathione peroxidase protein and selenium content in plasma, Blood 73, 318-323 (1989).
40. 75Se-P, a selenoprotein found in rat liver and plasma, and comparison of it with selenoglutathione peroxidase, Arch. Biochem. Biophys. 213, 73-80 (1982).
41. R. F. Burk and K. E. Hill, Selenoprotein P. A selenium-rich extracellular glycoprotein, J. Nutr. 124, 1891-1897 (1994).
42. R. F. Burk, K. E. Hill, R. Read, and T. Bellew, Response of rat selenoprotein P to selenium administration and fate of its selenium, Am. J. Physiol. 261, E26-E30 (1991).
43. M. Persson-Moschos, W. Huang, T. S. Srikumar, B. Akesson, and S. Lindeberg, Selenoprotein P in serum as a biochemical marker of selenium status, Analyst 120, 833-836 (1995).
44. J-G Yang, K. E. Hill, and R. F. Burk, Dietary selenium intake controls rat plasma selenoprotein P concentration, J. Nutr. 119, 1010-1012 (1989).
45. E. Marchaluk, M. Persson-Moschos, E. B. Thorling, and B. Akesson, Variation in selenoprotein P concentration in serum from different European regions, Eur. J. Clin. Nutr. 49, 42-48 (1995).
46. M. A. Motsenbocker, and A. L. Tappel, A selenocysteine-containing selenium-transport protein in rat plasma, Biochim. Biophys. Acta 719, 147-153 (1982).
47. J. G. Yang, J. Morrison Plummer, and R. F. Burk, Purification and quantitation of a rat plasma selenoprotein distinct from glutathione peroxidase using monoclonal antibodies, J. Biol. Chem. 262, 13,372-13,375 (1987).
48. M. J. Berry, J. D. Kieffer, J. W. Harney, and P. R. Larsen, Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase, J. Biol. Chem. 266, 14,155-14,158 (1991).
49. J. R. Arthur, F. Nicol, and G. J. Beckett, The role of selenium in thyroid hormone metabolism and effects of selenium deficiency on thyroid hormone and iodine metabolism, Biol. Trace Elem. Res. 33, 37-42 (1992).
50. J. R. Arthur, F. Nicol, and G. J. Beckett, Hepatic iodothyronine 5′-deiodinase. The role of selenium, Biochem. J. 272, 537-540 (1990).
51. J. R. Arthur, F. Nicol, A. R. Hutchinson, and G. J. Beckett, The effects of selenium depletion and repletion on the metabolism of thyroid hormones in the rat, J. Inorg. Biochem. 39, 101-108 (1990).
52. M. F. Robinson, and C. D. Thomson, The role of selenium in the diet, Nutr. Abst. Rev. Clin. Nutr. 53, 3-26 (1983).
53. M. Mutanen, Bioavailability of selenium, Ann. Clin. Res. 18,48-54 (1986).
54. M. F. Robinson, H. M. Rea, G. M. Friend, R. D. H. Stewart, P. C. Snow, and C. D. Thomson, On supplementing the selenium intake of New Zealanders. 2. Prolonged metabolic experiments with daily supplements of selenomethionine, selenite and fish, Br. J. Nutr. 39, 589-600 (1978).
55. 75Se]selenomethionine in four women, Br. J. Nutr. 35, 373-382 (1976).
56. O. A. Levander, G. Alfthan, H. Arvilommi, C. G. Gref, J. K. Huttunen, M. Kataja, P. Koivistoinen, and J. Pikkarainen, Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters, Am. J. Clin. Nutr. 37, 887-897 (1983).
57. J. R. Robinson, M. F. Robinson, O. A. Levander, and C. D. Thomson, Urinary excretion of selenium by New Zealand and North American human subjects on differing intakes, Am. J. Clin. Nutr. 41, 1023-1031 (1985).
58. B. A. Bopp, R. C. Sonders, and J. W. Kesterson, Metabolic fate of selected selenium compounds in laboratory animals and man, Drug Metab. Rev. 13, 271-318 (1982).
59. 74Se]selenomethionine metabolism: a kinetic model, Am. J. Clin. Nutr. 54, 917-926 (1991).
60. S. Wolffram, B. Berger, E. Scharrer, Transport of selenomethionine and methionine across the intestinal brush border membrane, in Selenium in Biology and Medicine, A. Wendel, ed., Springer-Verlag, Berlin, pp. 109-113 (1989).
61. G. O. Barbezat, C. E. Casey, P. G. Reasbeck, et al., Selenium, in Absorption and Malabsorption of Mineral Nutrients, N. W. Solomons and I. H. Rosenberg, eds., Liss Inc., New York, pp. 231-258 (1984).
62. B. H. Patterson, O. A. Levander, K. Helzlsouer, P. A. McAdam, S. A. Lewis, P. R. Taylor, C. Veillon, and L. A. Zech, Human selenite metabolism: a kinetic model, Am. J. Physiol. 257, R556-67 (1989).
63. D. B. Shennan, Selenium (selenate) transport by human placental brush border membrane vesicles, Br. J. Nutr. 59, 13-19 (1988).
64. C. D. Thomson and M. F. Robinson, Urinary and fecal excretions and absorption of a large supplement of selenium: superiority of selenate over selenite, Am. J. Clin. Nutr. 44, 659-663 (1986).
65. I. Dreosti, Selenium, J. Food Nutr. 43, 60-78 (1986).
66. A. Keys, J. T. Anderson and F. Grande, Prediction of serum-cholesterol responses of man to changes in fats in the diet, Lancet 2, 959-966 (1957).
67. A. T. Diplock, Trace elements in human health with special reference to selenium, Am. J. Clin. Nutr. 45, 1313-1322 (1987).
68. J. L. Greger and R. E. Marcus, Effect of dietary protein, phosphorus, and sulphur amino acids on selenium metabolism of adult males, Ann. Nutr. Metab. 25, 97-108 (1981).
69. M. Sandholm, Selenium carrier proteins in mouse plasma, Acta Pharmacol. Toxicol. 35, 424-428 (1974).
70. M. Sandholm, Function of erythrocytes in attaching selenite-Se onto specific plasma proteins, Acta Pharmacol. Toxicol. 36, 321-327 (1975).
71. E. K. Porter, J. A. Karle, and A. Shrift, Uptake of selenium-75 by human lymphocytes in vitro, J. Nutr. 109, 1901-1908 (1979).
72. 32, Biochim. Biophys. Acta 372, 255-265 (1974).
73. 74Se (in sodium selenite form), J. Inorg. Biochem. 55, 157-163 (1994).
74. J. A. Butler, C. D. Thomson, P. D. Whanger, and M. F. Robinson, Selenium distribution in blood fractions of New Zealand women taking organic or inorganic selenium, Am. J. Clin. Nutr. 53, 748-754 (1991).
75. G. Alfthan, A. Aro, H. Arvilommi, and J. K. Huttunen, Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite, and selenate, Am. J. Clin. Nutr. 53, 120-125 (1991).
76. C. D. Thomson, M. F. Robinson, D. R. Campbell, and H. M. Rea, Effect of prolonged supplementation with daily supplements of selenomethionine and sodium selenite on glutathione peroxidase activity in blood of New Zealand residents, Am. J. Clin. Nutr. 36, 24-31 (1982).
77. K. Jaakkola, J. Tummavuori, A. Pirinen, P. Kurkela, M. Tolonen, and A.U. Arstila Selenium levels in whole blood of Finnish volunteers before and during organic and inorganic selenium supplementation, Scand. J. Clin. Lab. Invest. 43, 473-476 (1983).
78. J. Neve, F. Vertongen, N. Thonnart, Y. A. Carpentier, Y. Gregoire, and L. Molle, Selenium supplementation during parenteral and enterai nutrition, short- and long-term effects of two derivatives, Acta Pharmacol Toxicol. Copenh. 59 (Suppl 7), 166-169 (1986).
79. C. D. Thomson, M. F. Robinson, J. A. Butler, and P. D. Whanger, Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women, Br. J. Nutr. 69, 577-588 (1993).
80. O. Oster, G. Schmiedel, and W. Prellwitz, The organ distribution of selenium in German adults, Biol. Trace Elem. Res. 15, 23-45 (1988).
81. D. Behne, A. Kyriakopoulos, S. Scheid, and H. Gessner, Effects of chemical form and dosage on the incorporation of selenium into tissue proteins in rats, J. Nutr. 121, 806-814 (1991).
82. N. Esaki, T. Nakamura, H. Tanaka, and K. Soda, Selenocysteine lyase, a novel enzyme that specifically acts on selenocysteine. Mammalian distribution and purification and properties of pig liver enzyme, J. Biol. Chem. 257, 4386-4391 (1982).
83. R. H. Patterson and L. A. Zech, Development of a model for selenite metabolism in humans, J. Nutr. 122, 709-714 (1992).
84. M. Janghorbani, R. F. Martin, L. J. Kasper, X. F. Sun, and V. R. Young, The selenite-exchangeable metabolic pool in humans: a new concept for the assessment of selenium status, Am. J. Clin. Nutr. 51, 670-677 (1990).
85. M. S. Alaejos and C. D. Romero, Urinary selenium concentrations, Clin. Chem. 39, 2040-2052 (1993).
86. O. Oster and W. Prellwitz, The renal excretion of selenium, Biol. Trace Elem. Res. 24, 119-146 (1990).
87. H. J. Robberecht and H. A. Deelstra, Selenium in human urine: concentration levels and medical implications, Clin. Chim. Acta 136, 107-120 (1984).
88. R. Hasunuma, M. Tsuda, T. Ogawa, and Y. Kawanishi, Selenium metabolite levels in human urine after dosing selenium in different chemical forms, Bull. Environ. Contain. Toxicol. 51, 756-763 (1993).
89. X. F. Sun, B. T. G. Ting, and M. Janghorbani, Excretion of trimethylselenonium ion in human urine, Anal. Biochem. 167, 304-311 (1987).
90. M. F. Robinson, C. P. Jenkinson, G. Luzhen, et al., Urinary excretion of selenium (Se) and trimethylselenonium (TMSe) by NZ women during long-term supplementation with selenate or selenomethionine (SeMet), in Selenium in Biology and Medicine, A. Wendel, ed., Springer-Verlag, Berlin, pp. 250-253 (1989).
91. C. D. Thomson, C. E. Burton, and M. F. Robinson, On supplementing the selenium intake of New Zealanders. 1. Short experiments with large doses of selenite or selenomethionine, Br. J. Nutr. 39, 579-587 (1978).
92. T. Westermarck, Selenium content of tissues in Finnish infants and adults with various diseases, and studies on the effects of selenium supplementation in neuronal ceroid lipofuscinosis patients, Acta Pharmacol. Toxicol. 41, 121-128 (1977).
93. C. E. Casey, B. E. Guthrie, G. M. Friend, and M. F. Robinson, Selenium in human tissues from New Zealand, Arch. Environ. Health 37, 133-135 (1982).
94. O. A. Levander, Considerations on the assessment of selenium status, Fed. Proc. 44, 2579-2583 (1985).
95. D. Behne, H. Hilmert, S. Scheid, et al., Studies on new selenoproteins and specific selenium target tissues, in Selenium in Biology and Medicine, A. Wendel, ed., Springer-Verlag, Berlin, pp. 14-20 (1989).
96. D. Behne, H. Hilmert, S. Scheid, H. Gessner, and W. Elger, Evidence for specific selenium target tissues and new biologically important selenoproteins, Biochim. Biophys. Acta 966, 12-21 (1988).
97. P. J. Smith, A. L. Tappel, and C. K. Chow, Glutathione peroxidase activity as a function of dietary selenomethionine, Nature 247, 392-393 (1974).
98. O. A. Levander, D. P. DeLoach, V. C. Morris, and P. B. Moser. Platelet glutathione peroxidase activity as an index of selenium status in rats, J. Nutr. 113, 55-63 (1983).
99. C. D. Thomson, S. M. Steven, A. M. van Rij, C. R. Wade, and M. F. Robinson, Selenium and vitamin E supplementation: activities of glutathione peroxidase in human tissues, Am. J. Clin. Nutr. 48, 316-323 (1988).